BackBriaCell Therapeutics Warrant Overview

BriaCell Therapeutics Warrant Accounts Payable

BriaCell Therapeutics Warrant's accounts payable is $0.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$0.00

Peer trimmed avg / median

Loading

BriaCell Therapeutics Warrant Accounts Payable History

Loading

BriaCell Therapeutics Warrant vs. peers: Accounts Payable Comparison

Loading

BriaCell Therapeutics Warrant Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BriaCell Therapeutics Warrant (BCTXZ) FAQ

As of the most recent data (July 2026), BCTXZ shows a accounts payable of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BCTXZ's accounts payable is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether BriaCell Therapeutics Warrant is outperforming or lagging.

Tracking BCTXZ's accounts payable over time shows whether BriaCell Therapeutics Warrant is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has BriaCell Therapeutics Warrant's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $0) with ownership activity and broader fundamentals.

BriaCell Therapeutics Warrant's accounts payable is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers